Johnson & Johnson (NYSE: JNJ) CEO receives 73,054 performance share units
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Johnson & Johnson CEO and Chairman Joaquin Duato reported receiving an equity award tied to company performance. On February 9, 2026, he acquired 73,054 Performance Share Units (PSUs) at a price of $0 per unit. These PSUs were originally granted on February 13, 2023 under the long-term incentive plan and convert into an equal number of Johnson & Johnson common shares upon vesting, based on performance conditions that were certified on February 9, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Duato Joaquin
Role
CEO and Chairman of the Board
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Performance Share Units | 73,054 | $0.00 | -- |
Holdings After Transaction:
Performance Share Units — 73,054 shares (Direct)
Footnotes (1)
- Performance Share Units (PSUs) awarded under Issuer's Long-Term Incentive Plan on February 13, 2023. The PSUs convert into shares of Common Stock upon vesting. The number of PSUs reflects the target number of PSUs originally granted on February 13, 2023, adjusted to reflect achievement relative to the performance conditions set forth in the award agreement, as certified on February 9, 2026.
FAQ
What insider transaction did JNJ CEO Joaquin Duato report on this Form 4?
Joaquin Duato reported acquiring 73,054 Performance Share Units on February 9, 2026. These units are part of Johnson & Johnson’s long-term incentive plan and convert into common stock after vesting, based on previously established performance conditions.
When were the performance conditions for the JNJ CEO’s 73,054 PSUs certified?
The performance conditions for the CEO’s PSU award were certified on February 9, 2026. That certification determined the final number of units, based on the original February 13, 2023 grant and the performance metrics in the award agreement.
Is the JNJ CEO’s Form 4 transaction a purchase or a compensation award?
The transaction is a compensation award, not an open-market purchase. It reflects a grant or other acquisition of 73,054 Performance Share Units under Johnson & Johnson’s long-term incentive plan, with a reported price of $0 per unit.